DarioHealth (DRIO) Gross Margin (2014 - 2026)

DarioHealth's Gross Margin history runs 13 years deep, the most recent figure standing at 57.31% for Q1 2026.

• Quarterly Gross Margin fell 19.0% year-over-year to 57.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.55% (up 405.0% YoY) and the FY2025 annual result came in at 56.64%, up 758.0% from the prior year.
• Gross Margin was 57.31% for Q1 2026 at DarioHealth, up from 53.6% in the prior quarter.
• Across five years, Gross Margin topped out at 60.22% in Q3 2025 and bottomed at 17.81% in Q4 2022.
• A 5-year average of 38.5% and a median of 44.83% in 2023 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2022 — Gross Margin slumped 2690 bps — and 2024, when it jumped 5161 bps.
• DarioHealth's Gross Margin stood at 17.81% in 2022, then surged by 120 bps to 3.65% in 2023, then soared by 1414 bps to 55.26% in 2024, then dropped by 3 bps to 53.6% in 2025, then grew by 7 bps to 57.31% in 2026.
• Business Quant data shows DRIO's Gross Margin at 57.31% in Q1 2026, 53.6% in Q4 2025, and 60.22% in Q3 2025.